With all the clinical stage resesrch positively linking CBD to various indications, CBD should be getting much more press outside industry sources/journals. Your points 2&3 are interesting. I wonder if the studies we see actually move forward. Waiting for the day when a pharma company announces JV etc with a CBD concern.
Market Data 
Markets 
AI
